Table 1

Characteristics of patients diagnosed with oesophageal (C15) and gastro-oesophageal cancer (C160)
Variable C15 C160 C15 & C160
N=3,456 N=1,568 N=5,024
n % n % n %
Age at diagnosis group (years)
<60 657 19.0 402 25.6 1,059 21.1
60–69 840 24.3 399 25.4 1,239 24.7
70–79 1,048 30.3 486 31.0 1,534 30.5
80+ 911 26.4 281 17.9 1,192 23.7
Gender
Female 1,159 33.5 362 23.1 1,521 30.3
Male 2,297 66.5 1,206 76.9 3,503 69.7
Country of Birth
Australia 2,497 72.2 1,063 67.8 3,560 70.9
Other 959 37.8 505 32.2 1,464 29.1
Histology group
SCC 1,478 42.8 70 4.5 1,548 30.8
Adenocarcinomas 1,549 44.8 1,398 89.2 2,947 58.7
Other 293 8.5 79 5.0 372 7.4
Degree of Spread
Localised 1,290 37.3 435 27.7 1,725 34.3
Regional 692 20.0 543 34.6 1,235 24.6
Distant 622 18.0 387 24.7 1,009 20.1
Unknown 721 20.9 203 12.9 924 18.4
Tumour location
Upper 297 8.6 297 5.9
Middle 470 13.8 470 9.4
Lower 1,528 45.0 1,528 30.9
NOS* 1,113 32.7 1,113 22.2
GOJ* 1,568 1,568 31.2
Charlson comorbidity
0 3,098 89.6 1,431 91.2 4,529 90.1
1,2 331 9.6 124 7.9 455 9.1
3+ 27 0.8 13 0.8 40 0.8

*NOS = not otherwise specified; GOJ = gastro-oesophageal junction.

Stavrou et al.

Stavrou et al. BMC Health Services Research 2012 12:384   doi:10.1186/1472-6963-12-384

Open Data